U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519681) titled 'Effects of Berberine on the Human Gut Microbiome' on March 22.
Brief Summary: Berberine hydrochloride is a conventional component in Chinese medicine. In recent years, anticancer activity of berberine hydrochloride have been explored. The aim of this study is to investigate the effect of berberine hydrochloride on the human gut microbiome.
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Colorectal Adenomas
Colorectal Cancers
Intervention:
DRUG: Berberine Hydrochloride
Oral Administration of Berberine Hydrochloride
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jing-yuan Fang, MD, Ph. D
Information provided...